IM-MS Irradiation Reduced Breast Cancer Mortality but Did Not Improve Overall Survival in Node-Negative Breast Cancer
BOT/BAL Shows 33% 3-Year OS in Refractory MSS mCRC Without Active Liver Metastases
WHO 2026 Global Cancer Report: Screening, Prevention and Treatment Gaps in GU Oncology
Douglas Flora: The Power of Clinicians Who Can Bridge AI and Human Care
Disitamab Vedotin, Tislelizumab, and S-1 Deliver High Response Rates in HER2-Overexpressing Advanced Gastric/GEJ Cancer
PICC-2: Toripalimab Plus Celecoxib Improves pCR in dMMR Locally Advanced Colorectal Cancer
2026 IBRI Global Forum on Science, Philanthropy, and Investment
FDA Immunotherapy Approvals: First Half of 2026
